Role and potential mechanisms of anabolic resistance in sarcopenia

Prashanth H. Haran1, Donato A. Rivas1, Roger A. Fielding1
1Nutrition, Exercise Physiology, and Sarcopenia Laboratory, Jean Mayer USDA Human Nutrition Research Center on Aging Tufts University 711 Washington Street 02111 Boston MA

Tóm tắt

There is pressing need to understand the aging process to better cope with its associated physical and societal costs. The age‐related muscle wasting known as sarcopenia is a major contributor to the problems faced by the elderly. By hindering mobility and reducing strength, it greatly diminishes independence and quality of life. In studying the factors that contribute to the development of sarcopenia, the focus is shifting to the study of disordered muscle anabolism. The abnormal response of muscle to previously well‐established anabolic stimuli is known as anabolic resistance, and may be a key factor in the development and progression of sarcopenia. Factors such as age, obesity, inflammation, and lipotoxicity contribute to anabolic resistance, and have been studied either directly or indirectly in cell systems and whole animals. Understanding the physiologic and mechanistic basis of anabolic resistance could be the key to formulating new and targeted interventions that would ease the burden currently borne by the world's aged population.

Từ khóa


Tài liệu tham khảo

WHO. Ageing (online). 2008.http://www.who.int/topics/ageing/en. Accessed 9 Aug 2011.

10.1111/j.1532-5415.2000.tb04719.x

10.1093/oxfordjournals.aje.a009520

10.1093/jn/127.5.990S

10.1007/BF02982705

10.1093/gerona/61.10.1059

10.1152/japplphysiol.00670.2007

10.1139/H09-012

10.1001/jama.286.10.1206

10.1113/jphysiol.2004.068841

Bennet WM, 1990, Euglycemic hyperinsulinemia augments amino acid uptake by human leg tissues during hyperaminoacidemia, Am J Physiol, 259, E185

10.1172/JCI117731

Hillier TA, 1998, Extreme hyperinsulinemia unmasks insulin's effect to stimulate protein synthesis in the human forearm, Am J Physiol, 274, E1067

10.2337/diabetes.52.6.1377

10.1096/fj.04-2640fje

10.1152/jappl.1996.81.6.2509

10.1079/PNS19950066

10.1093/ageing/afn144

10.1152/ajpendo.00366.2003

10.1139/h95-038

Phillips SM, 1997, Mixed muscle protein synthesis and breakdown after resistance exercise in humans, Am J Physiol, 273, E99

10.1113/jphysiol.2005.093690

10.1113/jphysiol.2008.164483

10.1038/ncb1101-1014

10.1038/ncb1101-1009

10.1152/physiol.00024.2006

10.4161/cc.10.16.17102

10.1038/nrm3025

10.1016/j.cmet.2006.04.008

10.1677/JOE-09-0202

10.1096/fj.03-1341fje

10.1096/fj.05-4607fje

10.1152/ajpendo.00037.2007

10.1139/H09-073

10.1113/jphysiol.2008.163816

10.1152/ajpregu.00277.2005

10.1093/gerona/glp026

10.1152/japplphysiol.01383.2003

10.1113/jphysiol.2006.107490

10.1111/j.1749-6632.2000.tb06498.x

10.1097/MCO.0b013e328312c37d

Kahn CR, 1994, Banting lecture. Insulin action, diabetogenes, and the cause of type II diabetes, Diabetes, 43, 1066, 10.2337/diab.43.8.1066

10.1016/j.metabol.2007.10.009

10.1210/jc.2008-2216

10.1210/en.2004-0921

10.1172/JCI29528

10.1152/ajpregu.00840.2010

10.1007/s11010-009-0130-5

10.1152/ajpendo.00314.2007

10.1172/JCI43378

10.1152/physiolgenomics.00249.2004

10.1152/ajpregu.00467.2009

10.1093/ajcn/82.2.428

Paolisso G, 1998, Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha, Am J Physiol, 275, E294

10.1093/gerona/53A.1.M20

10.1016/j.mad.2006.11.016

10.1152/ajpendo.90885.2008

10.1016/j.mce.2009.07.031

10.1097/MCO.0b013e32833aabd9

10.1074/jbc.R200008200

10.2337/diabetes.54.3.591

10.1111/j.1749-6632.2002.tb04288.x

Hyde R, 2005, Ceramide down-regulates System A amino acid transport and protein synthesis in rat skeletal muscle cells, FASEB J, 19, 461, 10.1096/fj.04-2284fje

10.2337/diabetes.50.10.2210

10.1371/journal.pone.0010578

10.1073/pnas.96.8.4438

10.2337/diabetes.50.11.2563

10.1016/j.plipres.2005.11.002

10.1111/j.1748-1716.2011.02289.x

10.1007/s13539-010-0003-5